A new study demonstrates that maternal RSV vaccination and nirsevimab significantly reduce infant RSV infection and healthcare use.
← News
Science Breakthroughs Science Breakthroughs Knowledge
Evaluating effectiveness of maternal RSV vaccination and nirsevimab for severe RSV-related illness in infants
Maternal RSV Vaccination Prevention method 1
Nirsevimab After Birth Prevention method 2
Significantly Lower RSV Infection Primary benefit
Substantially Decreased healthcare use
Significantly Lower infections reduced